BESSEMER GROUP INC - SUPERNUS PHARMACEUTICALS INC ownership

SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 235 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.09 and the average weighting 0.1%.

Quarter-by-quarter ownership
BESSEMER GROUP INC ownership history of SUPERNUS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$5
+25.0%
170
+11.1%
0.00%
Q2 2023$40.0%153
+41.7%
0.00%
Q1 2023$4
-20.0%
108
-19.4%
0.00%
Q4 2022$5
-99.9%
1340.0%0.00%
Q3 2022$5,000
+25.0%
1340.0%0.00%
Q2 2022$4,0000.0%1340.0%0.00%
Q1 2022$4,000
-20.0%
134
-15.7%
0.00%
Q4 2021$5,000
-28.6%
159
-45.0%
0.00%
Q4 2020$7,000
-12.5%
289
+5.1%
0.00%
Q3 2019$8,0002750.00%
Q2 2019$0
-100.0%
0
-100.0%
0.00%
-100.0%
Q4 2018$183,000
-33.9%
5,5000.0%0.00%0.0%
Q3 2018$277,000
-27.7%
5,500
-14.1%
0.00%0.0%
Q2 2018$383,000
-35.2%
6,400
-83.5%
0.00%
-66.7%
Q1 2016$591,000
-79.6%
38,723
-82.0%
0.00%
-81.2%
Q4 2015$2,892,000
+16.7%
215,147
+21.8%
0.02%
+14.3%
Q3 2015$2,478,000
+864.2%
176,635
+1068.2%
0.01%
+1300.0%
Q2 2015$257,00015,1200.00%
Other shareholders
SUPERNUS PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
HealthInvest Partners AB 335,000$8,934,00013.38%
ASHFORD CAPITAL MANAGEMENT INC 1,016,665$27,114,0002.46%
Bruce & Co., Inc. 402,105$10,724,0002.28%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 297,500$7,934,0001.91%
ARMISTICE CAPITAL, LLC 3,900,000$104,013,0001.76%
Bridge City Capital, LLC 108,884$2,904,0001.32%
S&T BANK/PA 316,098$8,430,0001.31%
Kent Lake Capital LLC 100,000$2,667,0001.15%
MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income 331,140$8,832,0001.02%
Prairiewood Capital, LLC 45,297$1,208,0000.99%
View complete list of SUPERNUS PHARMACEUTICALS INC shareholders